Page 33 - Vitamin D and Cancer

20 H.S. Cross

36. Kemmis CM, Welsh J (2008) Mammary epithelial cell transformation is associated with
deregulation of the vitamin D pathway. J Cell Biochem 105(4):980–988
37. Turunen MM, Dunlop TW, Carlberg C, Vaisanen S (2007) Selective use of multiple vitamin
D response elements underlies the 1 alpha, 25-dihydroxyvitamin D3-mediated negative regu-
lation of the human CYP27B1 gene. Nucleic Acids Res 35(8):2734–2747
38. Lechner D, Kallay E, Cross HS (2007) 1alpha, 25-dihydroxyvitamin D3 downregulates
CYP27B1 and induces CYP24A1 in colon cells. Mol Cell Endocrinol 263(1–2):55–64
39. Kallay E, Pietschmann P, Toyokuni S et al (2001) Characterization of a vitamin D receptor
knockout mouse as a model of colorectal hyperproliferation and DNA damage. Carcinogenesis
22(9):1429–1435
40. Liu N, Nguyen L, Chun RF et al (2008) Altered endocrine and autocrine metabolism of
vitamin D in a mouse model of gastrointestinal inflammation. Endocrinology
149(10):4799–4808
41. Cross HS, Bareis P, Hofer H et al (2001) 25-Hydroxyvitamin D(3)-1alpha-hydroxylase and
vitamin D receptor gene expression in human colonic mucosa is elevated during early can-
cerogenesis. Steroids 66(3–5):287–292
42. Cross HS, Bajna E, Bises G et al. (eds) (1996) Vitamin D receptor and cytokeratin expression
may be progression indicators in human colon cancer. Anticancer Res 16:2333–2337
43. Sheinin Y, Kaserer K, Wrba F et al (2000) In situ mRNA hybridization analysis and immu-
nolocalization of the vitamin D receptor in normal and carcinomatous human colonic
mucosa: relation to epidermal growth factor receptor expression. Virchows Arch
437(5):501–507
44. Tong WM, Kallay E, Hofer H et al (1998) Growth regulation of human colon cancer cells by
epidermal growth factor and 1, 25-dihydroxyvitamin D3 is mediated by mutual modulation
of receptor expression. Eur J Cancer 34(13):2119–2125
45. Bareis P, Kallay E, Bischof MG et al (2002) Clonal differences in expression of 25-hy-
droxyvitamin D(3)-1alpha- hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of
the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor
and 1alpha,25-dihydroxyvitamin D(3). Exp Cell Res 276(2):320–327
46. Palmer HG, Gonzalez-Sancho JM, Espada J et al (2001) Vitamin D(3) promotes the differ-
entiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-
catenin signaling. J Cell Biol 154(2):369–387
47. Pena C, Garcia JM, Silva J et al (2005) E-cadherin and vitamin D receptor regulation by
SNAIL and ZEB1 in colon cancer: clinicopathological correlations. Hum Mol Genet
14(22):3361–3370
48. Kemmis CM, Salvador SM, Smith KM, Welsh J (2006) Human mammary epithelial cells
express CYP27B1 and are growth inhibited by 25-hydroxyvitamin D-3, the major circulating
form of vitamin D-3. J Nutr 136(4):887–892
49. Barreto AM, Schwartz GG, Woodruff R, Cramer SD (2000) 25-Hydroxyvitamin D3, the
prohormone of 1, 25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic
epithelial cells. Cancer Epidemiol Biomarkers Prev 9(3):265–270
50. Wang L, Flanagan JN, Whitlatch LW, Jamieson DP, Holick MF, Chen TC (2004) Regulation
of 25-hydroxyvitamin D-1alpha-hydroxylase by epidermal growth factor in prostate cells.
J Steroid Biochem Mol Biol 89–90(1–5):127–130
51. Nonn L, Peng L, Feldman D, Peehl DM (2006) Inhibition of p38 by vitamin D reduces
interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phos-
phatase 5: implications for prostate cancer prevention by vitamin D. Cancer Res
66(8):4516–4524
52. Brozek W, Bises G, Fabjani G, Cross HS, Peterlik M (2008) Clone-specific expression,
transcriptional regulation, and action of interleukin-6 in human colon carcinoma cells. BMC
Cancer 8:13
53. Fernandez-Pol JA (2008) Modulation of EGF receptor protooncogene expression by growth
factors and hormones in human breast carcinoma cells. Crit Rev Oncog x2(2):173–185